An appropriate preventive approach to early death in STXBP1-related disorders requires careful treatment and monitoring of epilepsies (optimization of ASM, reduction of the frequency of GTC seizures, limitation of seizure triggers such as sleep deprivation and illness), and adequate education of caregivers (optimization of adherence to treatment, assessment of risk awareness). This evidence concerns the gene STXBP1 and epilepsy.